Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HYR-PB21 local infiltration for post-hemorrhoidectomy pain
ChiCTR2000041318Phase 4Recruiting
- Sponsor
- Beijing Chaoyang Hospital, Capital Medical University
- Start
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of HYR-PB21 in postoperative pain (3 arms), sponsored by Beijing Chaoyang Hospital, Capital Medical University. Primary endpoint: Resting pain score. Started Dec 2020; status: recruiting.
02
Drugs
HYR-PB21
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2000041318.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000041318.